Rosetta Genomics signs distribution agreement with Genetic Technologies for miRview(TM) tests
Oct 23, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Company: Rosetta Genomics Ltd (ROSG)
Rosetta Genomics, Ltd., an Israel-based developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited, an Australian life science company, have signed an exclusive distribution agreement for the former's three diagnostic tests.
According to the terms of the agreement, Genetic Technologies will market Rosetta Genomics' miRview(TM) mets, miRview(TM) squamous and miRview(TM) meso in Australia, New Zealand and Singapore.
Deal Type Partnership Sub-Category Marketing,Acquisition of Rights,Distribution Deal Status Announced: 2009-10-22
Deal Participants
Partner 1 (Company) Genetic Technologies Limited Partner 2 (Company) Rosetta Genomics, Ltd.
Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved
News Provided by COMTEX
Company: Rosetta Genomics Ltd (ROSG)
Related terms: acquisition, australia, israel, market, marketing, new zealand, partnership, singapore, technology
